EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer

Nicolo Formaggio, Jacopo Sgrignani, Gayathri Thillaiyampalam, Claudio Lorenzi, Giada A Cassanmagnago, Marco Coazzoli, Federico Costanzo, Yanick Uebelhart, Daniela Bossi, Diego Camuzi Cassiano, Andrea Rinaldi, Matteo Pecoraro und 5 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Nicolo Formaggio und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Oncology Research, Bellinzona, Switzerland; Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 3-alpha, Prostatic Neoplasms, Hepatocyte Nuclear Factor 3-beta, Cell Lineage. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer League, Swiss National Science Foundation, Swiss Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 3-alphaProstatic NeoplasmsHepatocyte Nuclear Factor 3-betaCell LineageCarcinogenesisMaleHumansReceptors, AndrogenCell Line, TumorCell ProliferationAnimalsMiceGene Expression Regulation, NeoplasticSignal Transduction

Stichwörter der Autor:innen

CP: CancerFOXA1FOXA2androgen receptor independenceandrogen receptor signalinglineage plasticitypioneer transcription factorprostate cancersmall molecule inhibitor

Substanzen

Hepatocyte Nuclear Factor 3-alphaHepatocyte Nuclear Factor 3-betaFOXA1 protein, humanReceptors, AndrogenFOXA2 protein, human

Autor:innen und Institutionen

  • Institute of Oncology Research, Bellinzona, Switzerland; Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.
  • Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland; Institute for Research in Biomedicine, Bellinzona, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Department of Molecular Mechanisms of Disease, University of Zurich, Zürich, Switzerland.
  • Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland; Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland; Institute for Research in Biomedicine, Bellinzona, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland. El…

Förderung

  • Swiss Cancer League
  • Swiss National Science Foundation
  • Swiss Cancer Foundation
  • Gustav and Ruth Jacob Foundation
  • Nelia and Amadeo Barletta Foundation

Zitieren

APA

Formaggio, N., Sgrignani, J., Thillaiyampalam, G., Lorenzi, C., Cassanmagnago, G. A., Coazzoli, M., Costanzo, F., Uebelhart, Y., Bossi, D., Cassiano, D. C., Rinaldi, A., Pecoraro, M., Geiger, R., Santoro, R., Bolis, M., Cavalli, A., & Theurillat, J. P. (2025). Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116324

Vancouver

Formaggio N, Sgrignani J, Thillaiyampalam G, Lorenzi C, Cassanmagnago GA, Coazzoli M, et al. Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116324

BibTeX
@article{Formaggio2025,
  author = {Formaggio, Nicolo and Sgrignani, Jacopo and Thillaiyampalam, Gayathri and Lorenzi, Claudio and Cassanmagnago, Giada A and Coazzoli, Marco and Costanzo, Federico and Uebelhart, Yanick and Bossi, Daniela and Cassiano, Diego Camuzi and Rinaldi, Andrea and Pecoraro, Matteo and Geiger, Roger and Santoro, Raffaella and Bolis, Marco and Cavalli, Andrea and Theurillat, Jean-Philippe},
  title = {Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116324}
}
Kostenlos starten →